Target intelligence / Profile preview

RNA, U6 small nuclear 398, pseudogene (RNU6-398P)

Target
RNU6-398P
Molecular classification
Other, Processed pseudogene, Non-coding RNA pseudogene
01

Overview

RNU6-398P is a processed pseudogene sequence derived from the U6 small nuclear RNA gene (snRNA). U6 snRNA is an essential component of the spliceosome, participating in the removal of introns from pre-mRNA in eukaryotes. Pseudogenes like RNU6-398P arise by retrotransposition events in which a copy of U6 snRNA is reverse-transcribed and inserted into the genome. As a pseudogene, RNU6-398P does not encode a functional RNA and generally lacks regulatory regions required for transcription[2][3][4]. Most processed pseudogenes, including those from snRNAs, are considered nonfunctional, having no known role in cellular biology, disease, or pharmaceutical targeting[2][4]. The existence of these pseudogenes is a common feature of vertebrate genomes and underscores the evolutionary importance of the parent U6 snRNA gene, but the pseudogene itself is not an active element in gene expression, splicing, or disease mechanisms[3][4]. Key notes: - RNU6-398P is not a functional receptor, enzyme, transporter, or drug target. - It is a processed pseudogene (more specifically, a pseudogene of a small nuclear RNA gene), thus it is not a therapeutic target[4][2]. - "RNU6-398P" is the standard gene name/abbreviation for this sequence. - No drugs, biomarkers, or disease roles are associated with this pseudogene. - If your intent is to find functional or druggable targets, this is not an appropriate entry, and its inclusion as a "target" would be considered incorrect in most biomedical contexts[2][4].

Other names
RNU6-398PRNA, U6 small nuclear 398, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 398, pseudogene (RNU6-398P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 398, pseudogene (RNU6-398P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call